Patent Losses Could Sink Allergan
February 05, 2018 at 09:04 AM EST
Allergan reports Q4 earnings on Tuesday. The company faces patent losses for Restasis, Combigan and Estrace. They represent a combined 15% of total revenue.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|